It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash

By Sam | January 25, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-actelion-jean-paul-clozel.jpg" NAME"It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash" ALT"It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash"January 26, 2017By <A HREF"http…
Source: BioSpace

Posted in BioPharma